EntryPoint Capital’s Janux Therapeutics JANX Stock Holding History

EntryPoint Capital’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$655K	Buy
2024 Q3	–	Sell
2024 Q2	$69.1K	Buy